CD4+ T cell count as a tool to monitor HIV progression & anti-retroviral therapy

Indian Journal of Medical Research

Volumn 121, Issue 4, 2005, Pages 539-549

  Pattanapanyasat, Kovit ^b   Thakar, Madhuri R ^a  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

CD4+ T lymphocytes flow cytometry; Quality control

Indexed keywords

ANTIRETROVIRUS AGENT;

ACCURACY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANALYTICAL EQUIPMENT; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LABORATORY TEST; LYMPHOCYTE COUNT; METHODOLOGY; MONITORING; NONHUMAN; QUALITY CONTROL; REVIEW; STANDARDIZATION; T LYMPHOCYTE;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HUMANS; QUALITY ASSURANCE, HEALTH CARE;

EID: 18844435627     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. CDC. Pneumocystis pneumonia - Los Angeles. MMWR 1981; 30 : 250-2.
2. UNAIDS/WHO AIDS Epidemic Update Part II. 2003; http://www.who.int/hiv/pub/epidemiology/eu/epiupdate2003II-en.pdf. Accessed on March 18, 2005.
3. Quinn TC. World AIDS Day: Reflections on the pandemic. The Hopkins HIV Report 2003; 15 : 12-4.
4. IAS International AIDS Society Team. Access to HAART for the developing world the next hurdle: Affordable laboratory monitoring (part 1), December 2002. http://www.impactaids.org.uk/articles.htm.
5. WHO "Treating 3 Million by 2005, Making It Happen". The WHO Strategy, WHO 2003. http://www.who.int/3by5/publications/documents/en /3by5StrategyMaingItHappen.pdf. Accessed on March 18, 2005.
6. Kovacs JA, Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N Engl J Med 2003; 342 : 1416-29.
7. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents.Department of Health and Human Services and Henry J Kaiser Family Foundation. MMWR Recomm Rep 1998; 47 : 43-82.
8. http://www.nacoonline.org/guidelines/ART_Guidelines.pdf. Accessed on March 18, 2005.
9. Saxena RK, Choudhry V, Nath I, Das SN, Paranjape RS, Babu G, et al. Normal ranges of some selected lymphocyte sub-populations in peripheral blood of normal healthy Indians. Curr Sci 2004: 86 : 969-75.
10. National Committee for Clinical Laboratory Standards. Clinical Applications of Flow Cytometry: Quality assurance and immunophenotyping of peripheral blood lymphocytes Tentative Guidelines. NCCLS publication H42-T, Villnova, PA, 1992.
11. Uppal SS, Verma S, Dhot PS. Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effects of sex, age, ethnicity, and smoking. Cytometry 2003; 52 : 32-6.
12. Ramalingam S, Kannangai R, Zachariah A, Mathai D, Abraham C. CD4 counts of normal and HIV-infected south Indian adults: do we need a new staging system? Natl Med J India 2001; 14 : 335-9.
13. Revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Centers for Disease Control. MMWR Recomm Rep 1997; 46 : 1-29.
14. Mandy FF, Nicholson JK, McDougal JS. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus.Centers for Disease Control. MMWR Recomm Rep 2003; 52 : 1-13.
15. Rachlis AR, Zarowny DP. Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group. CMAJ 1998; 158 : 496-505.
16. Mandy FF, Bergeron M, Minkus T. Evolution of leukocyte immunophenotyping as influenced by the HIV/AIDS pandemic: A short history of the development of gating strategies for CD4+ T-cell enumeration. Cytometry 1997; 30 : 157-65.
17. Gelman R, Wilkening C. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3+CD4+%. Cytometry 2000; 42 : 1-4.
18. Thompson JM, Gralow JR, Levy R, Miller RA. The optimal application of forward and ninety-degree light scatter in flow cytometry for the gating of mononuclear cells. Cytometry 1985; 6 : 401-6.
19. Loken MR, Brosnan JM, Bach BA, Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990; 11 : 453-9.
20. Nicholson JKA, Jones BM, Hubbard M. CD4 T-lymphocyte determinations on whole blood specimens using a single-tube three-color assay. Cytometry 1993; 14 : 685-9.
21. Pattanapanyasat K, Kyle DE, Tongtawe P, Yongvanitchit K, Fucharoen S. Flow cytometric immunophenotyping of lymphocyte subsets in samples that contain a high proportion of non-lymphoid cells. Cytometry 1994; 18 : 199-208.
22. Bergeron M, Nicholson JKA, Phaneuf S, Ding T, Soucy N, Badley AD, et al. Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens. Cytometry 2002; 50 : 53-61.
23. Janossy G, Jani IV, Goehde W. Affordable CD4+ T cell counts on "single-platform" flow cytometers I. Primary CD4 gating. Br J Haematol 2000; 111 : 1198-208.
24. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeucogating for accurate cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 2002; 50 : 69-77.
25. Aboulker JP, Autran B, Beldjord K, Touraine F, Debre P. Consistency of routine measurements of CD4+, CD8+ peripheral blood lymphocytes. J Immunol Methods 1992; 154 : 155-61.
26. Cohen AJ, Peerschke EIB, Steigbigel RT. A comparison of the Coulter STKS, Coulter S+IV, and manual analysis of white blood cell differential counts in a human immunodeficiency virus-infected population. Am J Clin Pathol 1993; 100 : 611-7.
27. Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1 infected patients: Total lymphocyte count fluctuation and diurnal cycle are important. J Acquir Immune Defic Syndr 1990; 3 : 144-51.
28. Taylor JMG, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J Acquir Immune Defic Syndr 1989; 2 : 114-24.
29. Giorgi JV. Characterization of T lymphocyte subset alteration by flow cytometry in HIV disease. Ann NY Acad Sci 1993; 677 : 126-37.
30. http://www.bd.com. Accessed on March 18, 2005.
31. http://www.guavatechnologies.com/main/index.cfm
32. http://www.partec.de. Accessed on March 18, 2005.
33. WHO Global Programme on AIDS (1994) Report of a WHO workshop on flow cytometry and alternative methodologies for CD4 lymphocyte determinations: Applications for developing countries. Washington, D.C., 16 April 1992, AIDS 8, WHO1-WHO4, Geneva.
34. Carella AV, Miss MW, Provost V, Quinn TC. A manual bead assay for the determination of absolute CD4+ and CD8+ lymphocyte counts in human immunodeficiency virus-infected individuals. Clin Diagn Lab Immunol 1995; 2 : 623-5.
35. Nicholson JKA, Velleca WM, Jubert S, Green TA, Bryan L. Evaluation of alternative CD4 technologies for the enumeration of CD4 lymphocytes. J Immunol Methods 1994; 177 : 43-54.
36. http://www.beckmancoulter.com. Accessed on March 18, 2005.
37. Balakrishnan P, Dunne M, Kumarasamy N, Crowe S, Subbulakshmi G, Ganesh AK, et al. An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries. J Acquir Immune Defic Syndr 2004; 36 : 1006-10.
38. http://www.dynalbiotech.com. Accessed on March 18, 2005.
39. Bi X, Gatanaga H, Tanaka M, Honda M, Ida S, Kimura S, et al. Modified dynabeads method for enumerating CD4+ T-lymphocyte count for widespread use in resource-limited situations. J Acquir Immune Defic Syndr 2005; 38 : 1-4.
40. + T lymphocytes in resource-limited settings: the ANRS 12-26 study. AIDS 2003; 17 : 2201-8.
41. + T-Cell Counts Estimated by an immunocapture technique (Capcellia) with viral loads in human immunodeficiency virus-seropositive individuals. Clin Diagn Lab Immunol 2001; 8 : 1286-8.
42. Kannangai R, Prakash KJ, Ramalingam S, Abraham OC, Mathews KP, Jesudason MV, et al. Peripheral CD4+/CD8+ T-lymphocyte counts estimated by an immunocapture method in the normal healthy south Indian adults and HIV seropositive individuals. J Clin Virol 2000; 17 : 101-8.
43. Didier J-M, Kazatchkine MD, Demouchy C, Moat C, Diagbouga, Serge S, et al. Comparative assessment of five alternative methods for CD4+ T lymphocyte enumeration for implementation in developing countries. J Acquir Immune Defic Syndr 2001; 26 : 193-5.
44. Mwaba P, Cassol S, Pilon R, Chintu C, Janes M, Nunn A, et al. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV infected patients. Lancet 2003; 362 : 1459-60.
45. http://www.ekneqas.org.uk. Accessed on March 18, 2005.
46. Rickman W, Waxdal M, Monical C, Damato J, Burke D. Department of Army lymphocyte immunophenotyping quality assurance program. Clin Immunol Immunopathol 1989; 52 : 85-94.
47. http://www.phac-aspc.gc.ca/nlhi-1niv/activ2_e.html. Accessed on March 18, 2005.